Jones RT - Search Results

1

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

Mendelson J, Jones RT. Mendelson J, et al. Among authors: jones rt. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S29-37. doi: 10.1016/s0376-8716(03)00057-7. Drug Alcohol Depend. 2003. PMID: 12738348 Review.

2

Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations.

Nath RP, Upton RA, Everhart ET, Cheung P, Shwonek P, Jones RT, Mendelson JE. Nath RP, et al. Among authors: jones rt. J Clin Pharmacol. 1999 Jun;39(6):619-23. doi: 10.1177/00912709922008236. J Clin Pharmacol. 1999. PMID: 10354966 Clinical Trial.

3

Bioavailability of sublingual buprenorphine.

Mendelson J, Upton RA, Everhart ET, Jacob P 3rd, Jones RT. Mendelson J, et al. Among authors: jones rt. J Clin Pharmacol. 1997 Jan;37(1):31-7. doi: 10.1177/009127009703700106. J Clin Pharmacol. 1997. PMID: 9048270

4

Buprenorphine and naloxone interactions in opiate-dependent volunteers.

Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ. Mendelson J, et al. Among authors: jones rt. Clin Pharmacol Ther. 1996 Jul;60(1):105-14. doi: 10.1016/S0009-9236(96)90173-3. Clin Pharmacol Ther. 1996. PMID: 8689806 Clinical Trial.

5

Buprenorphine and naloxone interactions in methadone maintenance patients.

Mendelson J, Jones RT, Welm S, Brown J, Batki SL. Mendelson J, et al. Among authors: jones rt. Biol Psychiatry. 1997 Jun 1;41(11):1095-101. doi: 10.1016/S0006-3223(96)00266-1. Biol Psychiatry. 1997. PMID: 9146820 Clinical Trial.

6

Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine.

Everhart ET, Cheung P, Shwonek P, Zabel K, Tisdale EC, Jacob P 3rd, Mendelson J, Jones RT. Everhart ET, et al. Among authors: jones rt. Clin Chem. 1997 Dec;43(12):2292-302. Clin Chem. 1997. PMID: 9439446

7

A controlled trial of fluoxetine in crack cocaine dependence.

Batki SL, Washburn AM, Delucchi K, Jones RT. Batki SL, et al. Among authors: jones rt. Drug Alcohol Depend. 1996 Jun;41(2):137-42. doi: 10.1016/0376-8716(96)01233-1. Drug Alcohol Depend. 1996. PMID: 8809502 Clinical Trial.

8

Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.

Jones RT. Jones RT. NIDA Res Monogr. 1997;175:221-34. NIDA Res Monogr. 1997. PMID: 9467801 Review. No abstract available.

9

Evaluation of opioid modulation in major depressive disorder.

Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M. Ehrich E, et al. Neuropsychopharmacology. 2015 May;40(6):1448-55. doi: 10.1038/npp.2014.330. Epub 2014 Dec 18. Neuropsychopharmacology. 2015. PMID: 25518754 Free PMC article. Clinical Trial.

10

The pharmacology of cocaethylene in humans following cocaine and ethanol administration.

Harris DS, Everhart ET, Mendelson J, Jones RT. Harris DS, et al. Among authors: jones rt. Drug Alcohol Depend. 2003 Nov 24;72(2):169-82. doi: 10.1016/s0376-8716(03)00200-x. Drug Alcohol Depend. 2003. PMID: 14636972 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results